Long-Term Outcomes of a Multicenter Aspirin Deprescribing Intervention

2026/05/14 by Avilasha Sinha, Josh Errickson, Xiaokui Gu +10 · 1 voice
Medicine · #Antiplatelet Therapy and Cardiovascular Diseases #Aspirin #Atrial Fibrillation Management and Outcomes #Deprescribing #Intervention (counseling) #Multicenter study #Quality of life (healthcare) #Venous Thromboembolism Diagnosis and Management #Warfarin

paper · doi:10.1001/jamanetworkopen.2026.12617

openalex publication_date 2026/05/14 · openalex created_date 2026/05/15 · openalex updated_date 2026/07/22

Abstract

This quality improvement study examines whether an aspirin deprescription intervention is associated with a sustained decrease in aspirin use among patients receiving warfarin for venous thromboembolism and/or atrial fibrillation.

Discussions

• Wayne State researchers contribute to new evidence supporting long-term aspirin deprescribing strategies in anticoagulated patients. doi.org/10.1001/jama... [bsky, 0 points, 0 comments]

Related

• Aspirin Deprescribing Interventions for Primary Prevention: A Systematic Review and Proposed Guidance for Deprescribing
• Aspirin Use to Prevent Cardiovascular Disease
• A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy
• Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
• Polypill with or without Aspirin in Persons without Cardiovascular Disease